| Cell line name |
M24 |
|---|
| Synonyms |
UCLA-SO-M24; UCLA-SO-24 |
|---|
| Accession |
CVCL_D032 |
|---|
| Resource Identification Initiative |
To cite this cell line use: M24 (RRID:CVCL_D032) |
|---|
| Comments |
Group: Patented cell line.
Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12270.
Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. |
|---|
| Sequence variations |
|
|---|
| HLA typing |
Source: PubMed=15592718
| Class I | | HLA-A | A*02:01,68:01:01 | | HLA-B | B*40:01:01,40:02 | | HLA-C | C*03:04,02:02:02 | | Class II | | HLA-DP | DPB1*04:01 | | HLA-DQ | DQB1*03:01:01,05:02 | | HLA-DR | DRB1*04:01:01,16:02 |
|
|---|
| Disease |
Amelanotic melanoma (NCIt: C3802) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Children:
|
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| STR profile |
Source(s): ESTDAB=ESTDAB-043; ESTDAB=ESTDAB-134
Markers:
Run an STR similarity search on this cell line |
|---|
| Publications | PubMed=2009538
Barbara M. Mueller, Cynthia A. Romerdahl, Jeffrey M. Trent, Ralph Alfred Reisfeld;
Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor.
Cancer Res. 51:2193-2198(1991) Patent=US5840317
Donald Lee Morton;
Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen.
Patent number US5840317, 24-Nov-1998 Patent=US5993828
Donald Lee Morton;
Tumor associated antigen compositions and methods.
Patent number US5993828, 30-Nov-1999 PubMed=15592718; DOI=10.1007/s00262-004-0561-5; PMCID=PMC11032966
Teresa Rodriguez, Rosa Mendez, Chrissy H. Roberts, Francisco Ruiz-Cabello Osuna, I. Anthony Dodi, Miguel Angel Lopez-Nevot, Laura Paco, Isabel Maleno, Steven G.E. Marsh, Graham Pawelec, Federico Garrido;
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Cancer Immunol. Immunother. 54:141-148(2005) PubMed=23851445; DOI=10.1158/1541-7786.MCR-13-0006
Christina Dahl, Claus Christensen, Goran Jonsson, Anders Lorentzen, Mette Louise Skjodt, Ake Borg, Graham Pawelec, Per Guldberg;
Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RARbeta signaling.
Mol. Cancer Res. 11:1166-1178(2013) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_D032
ESTDAB; ESTDAB-043
ESTDAB; ESTDAB-134
|
|---|
| Encyclopedic resources |
Wikidata; Q54903558
|
|---|
| Polymorphism and mutation databases |
Cosmic; 2163789
|
|---|
| Entry history |
|---|
| Entry creation | 22-Oct-2012 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 19 |
|---|
